191 related articles for article (PubMed ID: 7676627)
21. Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression.
Takakuwa T; Luo WJ; Ham MF; Sakane-Ishikawa F; Wada N; Aozasa K
Am J Pathol; 2004 Mar; 164(3):967-74. PubMed ID: 14982850
[TBL] [Abstract][Full Text] [Related]
22. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells.
Maruo S; Nanbo A; Takada K
J Virol; 2001 Oct; 75(20):9977-82. PubMed ID: 11559830
[TBL] [Abstract][Full Text] [Related]
23. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
[TBL] [Abstract][Full Text] [Related]
24. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
[TBL] [Abstract][Full Text] [Related]
25. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.
Minarovits J; Minarovits-Kormuta S; Ehlin-Henriksson B; Falk K; Klein G; Ernberg I
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1591-9. PubMed ID: 1649897
[TBL] [Abstract][Full Text] [Related]
26. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
27. Non-Random Pattern of Integration for Epstein-Barr Virus with Preference for Gene-Poor Genomic Chromosomal Regions into the Genome of Burkitt Lymphoma Cell Lines.
Janjetovic S; Hinke J; Balachandran S; Akyüz N; Behrmann P; Bokemeyer C; Dierlamm J; Murga Penas EM
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062290
[TBL] [Abstract][Full Text] [Related]
28. Identification of Epstein-Barr virus integrated sites in lymphoblastoid cell line (IB4).
Takakuwa T; Luo WJ; Ham MF; Wada N; Aozasa K
Virus Res; 2005 Mar; 108(1-2):133-8. PubMed ID: 15681063
[TBL] [Abstract][Full Text] [Related]
29. Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines.
Delecluse HJ; Bartnizke S; Hammerschmidt W; Bullerdiek J; Bornkamm GW
J Virol; 1993 Mar; 67(3):1292-9. PubMed ID: 8382295
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV.
Guan M; Romano G; Henderson EE
Anticancer Res; 1999; 19(4B):3007-17. PubMed ID: 10652585
[TBL] [Abstract][Full Text] [Related]
31. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
[TBL] [Abstract][Full Text] [Related]
32. Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis.
Sugden B; Warren N
Mol Biol Med; 1988 Apr; 5(2):85-94. PubMed ID: 2840551
[TBL] [Abstract][Full Text] [Related]
33. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T
Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621
[TBL] [Abstract][Full Text] [Related]
34. [Identification of EBV chromosomal integration sites in Raji cells by fluorescence in situ hybridization].
Gao J; Li X; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):13-9. PubMed ID: 19197121
[TBL] [Abstract][Full Text] [Related]
35. Discordant expression of 2 Epstein-Barr virus-associated antigens, EBNA and RANA, in man-rodent somatic cell hybrids.
Slovin SF; Glassy MC; Dambaugh T; Catalano MA; Curry RA; Ferrone S; Kieff E; Vaughan JH; Carson DA
J Immunol; 1981 Aug; 127(2):585-90. PubMed ID: 6265553
[TBL] [Abstract][Full Text] [Related]
36. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
Koopman LA; Szuhai K; van Eendenburg JD; Bezrookove V; Kenter GG; Schuuring E; Tanke H; Fleuren GJ
Cancer Res; 1999 Nov; 59(21):5615-24. PubMed ID: 10554043
[TBL] [Abstract][Full Text] [Related]
37. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers.
Zeuthen J; Klein G; Ber R; Masucci G; Bisballe S; Povey S; Terasaki P; Ralph P
J Natl Cancer Inst; 1982 Feb; 68(2):179-95. PubMed ID: 6278187
[TBL] [Abstract][Full Text] [Related]
38. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
Van Kuyk R; Mosier DE
Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
[TBL] [Abstract][Full Text] [Related]
39. The LCR of EBV makes Burkitt's lymphoma endemic.
Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
[TBL] [Abstract][Full Text] [Related]
40. The biology and serology of Epstein-Barr virus (EBV) infections.
Klein G
Bull Cancer; 1976; 63(3):399-410. PubMed ID: 187269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]